Records containing: Stage IVA Prostate Cancer AJCC v8
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-07-15Phase 2 Study of High Dose-Rate Brachytherapy and Stereotactic Body Radiotherapy for Intermediate and High Risk Localized Prostate Adenocarcinoma (HYDRA)
-
CLINICAL_TRIALS study record update · 2025-07-11Randomized Phase II Trial of Niraparib With Standard Combination Radiotherapy and Androgen Deprivation Therapy (ADT) in High Risk Prostate Cancer (With Initial Phase I) (NADIR*) *Randomized Phase II Trial of Niraparib With Standard Combination Androgen DeprIvation Therapy (ADT) and Radiotherapy in High Risk Prostate Cancer (With Initial Phase I)
-
CLINICAL_TRIALS study record update · 2025-06-22Extremely Hypofractionated Intensity Modulated Stereotactic Body Radiotherapy for Adjuvant or Salvage Treatment for Rising PSA After Radical Prostatectomy (EXCALIBUR)
-
CLINICAL_TRIALS study record update · 2025-05-20A First-in-Human, Phase I PET Imaging Study of 11C-YJH08, a Selective Glucocorticoid Receptor-Targeting Agent, in Patients With Advanced Solid Tumor Malignancies
-
CLINICAL_TRIALS study record update · 2025-05-07AtezoCab: A Phase II Study of Cabozantinib in Combination With Atezolizumab in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) With Non-Measurable Disease
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-04-23Hyperpolarized 13-C-Pyruvate Magnetic Resonance Spectroscopic Imaging Reproducibilty Pilot in Patients With Prostate Cancer
-
CLINICAL_TRIALS study record update · 2024-10-16A Phase 2 Study of 68Ga-PSMA-11 PET in Patients With Metastatic Castration Resistant Prostate Cancer
-
CLINICAL_TRIALS study record update · 2024-08-14Precision Pharmacogenomics in Cancer Patients
-
CLINICAL_TRIALS study record update · 2024-04-29Assessing Health Literacy and Interpreter Use in Radiation Oncology at LAC+USC Medical Center
-
CLINICAL_TRIALS study record update · 2024-04-16A Single Arm Phase II Study of Bone-Targeted Sn-117m-DTPA in Symptomatic Castration Resistant Prostate Cancer With Skeletal Metastases
-
CLINICAL_TRIALS study record update · 2024-03-07Gallium-68 PSMA-11 PET in Participants With Prostate Cancer
-
CLINICAL_TRIALS study record update · 2023-11-18A Phase I Study of SOR-C13 in Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2023-10-26Radiation Enhancement of Local and Systemic Anti-Prostate Cancer Immune Responses
-
CLINICAL_TRIALS study record update · 2023-10-18A Phase I Study to Evaluate PSCA-Targeting Chimeric Antigen Receptor (CAR)-T Cells for Patients With PSCA+ Metastatic Castration Resistant Prostate Cancer
-
CLINICAL_TRIALS study record update · 2023-10-16Phase Ib/II Study of Enzalutamide With Venetoclax (ABT-199) in Patients With Metastatic Castrate Resistant Prostate Cancer (mCRPC)
-
CLINICAL_TRIALS study record update · 2023-09-28Erdafitinib Plus Abiraterone Acetate or Enzalutamide in Double Negative Prostate Cancer
-
CLINICAL_TRIALS study record update · 2023-09-21A Phase I Study of AZD8186 in Combination With Docetaxel in Patients With PTEN Mutated or PIK3CB Mutated Advanced Solid Tumors, Potentially Amenable to Docetaxel
-
CLINICAL_TRIALS study record update · 2023-04-07Pharmacokinetic Comparison of Selective Prostatic Arterial and Intravenous PSMA Radioligand Infusions in Treatment-Naïve Prostate Cancer Patients
-
CLINICAL_TRIALS study record update · 2023-03-29Modifying Metabolic Syndrome and Cardiovascular Risk for Prostate Cancer Patients on ADT Using a Supervised Exercise Program and Continuous Fitbit Monitoring
-
CLINICAL_TRIALS study record update · 2022-10-21Head-to-Head Comparison of 68Ga-PSMA-11 PET/CT With 99mTc-MDP Bone Scan and CT for Detection of M1b Disease in Prostate Cancer Patients With Biochemical Progression During ADT
-
CLINICAL_TRIALS study record update · 2022-10-05Phase Ib/II Study of Enzalutamide With Decitabine, a DNA Hypomethylating Agent, in Patients With Metastatic Castrate Resistant Prostate Cancer (mCRPC)
-
CLINICAL_TRIALS study record update · 2022-09-21Effects of Novel Androgen Receptor Signaling Inhibitors on PSMA PET Signal Intensity in Patients With Castrate-Resistant Prostate Cancer: A Prospective Exploratory Study
-
CLINICAL_TRIALS study record update · 2022-05-25A Pilot Trial to Explore the Link Between Immunological Changes, Efficacy, Safety, and Tolerability of Durvalumab (MEDI4736) Plus Tremelimumab in Chemotherapy-Naïve Men With Metastatic Castration-Resistant Prostate Cancer (CRPC)
-
CLINICAL_TRIALS study record update · 2021-09-30Impact of 68GA-PSMA-11 PET/CT on Initial and Subsequent Treatment Strategies of Patients With Prostate Cancer
-
CLINICAL_TRIALS study record update · 2021-01-20Phase 2 Response Evaluation of Finite Systemic Therapy With Advanced Androgen Signaling Inhibition and Radiation Therapy for Oligorecurrent Prostate Cancer (RESTART)